FDA Oncology Announcements

Aromatase inhibitor third generation × Clear all

2 Announcements

Palbociclib

Drugs: IBRANCE (palbociclib) · CDK inhibitor, letrozole · Aromatase inhibitor third generation
Condition: Breast

Everolimus 2012

Drugs: Afinitor (everolimus) · MTOR inhibitor, exemestane · Aromatase inhibitor third generation
Condition: Breast